Furthermore, the progression of liver disease and portal hypertension leads to progressive vasodilatation, which reduces the effective arterial blood volume and results in the activation of the sympathetic nervous system as well as the renin-angiotensin-aldosterone system (RAAS). The gene discussed is REN; the disease is liver disorder.